Tonix Pharmaceuticals Holding Corp.(NASDAQ : TNXP)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CTLT | Catalent, Inc. | 0.58% | 85.68 | 2.1% | $236.46m | |
| SAVA | Cassava Sciences, Inc. | 0.88% | 11.51 | 0.0% | $215.42m | |
| HZNP | Horizon Therapeutics Plc | -0.61% | 77.68 | 5.8% | $168.24m | |
| JAZZ | Jazz Pharmaceuticals Plc | 2.04% | 142.59 | 2.4% | $167.73m | |
| MRNS | Marinus Pharmaceuticals, Inc. | 10.59% | 12.85 | 7.8% | $139.82m | |
| CORT | Corcept Therapeutics, Inc. | -0.83% | 17.41 | 5.5% | $123.16m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 4.50% | 15.55 | 14.1% | $91.50m | |
| BHC | Bausch Health Cos., Inc. | 4.50% | 15.55 | 0.0% | $64.17m | |
| MYOK | MyoKardia, Inc. | 1.64% | 136.33 | 1.8% | $63.39m | |
| AMRN | Amarin Corp. Plc | 4.21% | 4.21 | 1.5% | $60.54m | |
| ARGX | argenx SE | 0.89% | 262.52 | 0.0% | $53.94m | |
| SAGE | SAGE Therapeutics, Inc. | 2.43% | 61.12 | 8.6% | $44.03m | |
| GWPH | GW Pharmaceuticals Plc | -0.48% | 97.35 | 6.2% | $39.09m | |
| AXSM | Axsome Therapeutics, Inc. | -1.43% | 71.25 | 1.9% | $37.48m | |
| PRGO | Perrigo Co. Plc | 0.53% | 45.91 | 6.8% | $37.00m |
Company Profile
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.